Your new post is loading...
According to Gideon Mantel, co-founder and CEO of Treato, social media can predict the success of a new drug launch much faster than traditional methods.
"Many pharmaceutical companies try to measure the success of their launch based on weekly script trends," said Mantel in a blog post. "The difference between social media data and data derived from prescriptions is significant: social media data can predict the future, while script data record the past."
To illustrate this, Treato looked at patient-written social media posts on over 2,000 health blogs and forums to find mentions of Tecfidera (formerly called BG-12 during clinical trials), a new multiple sclerosis drug that Biogen launched on April 13. Since the launch of Tecfidera in mid-April, the most talked about MS drug in social media has been Tecfidera, bypassing all other MS medications and growing on a daily basis.
Listen to this conversation with Mantel: http://bit.ly/Mantelconvo
Via Pharma Guy
